Key result
Pharmacist-led follow-up is linked to significantly improved ASCVD risk and cardiovascular risk factor profiles.
Why the study?
The role of pharmacists in modifying cardiovascular disease risk factors among Lebanese adults in urban and rural areas was not well assessed.
Does a pharmacist-led monitoring and follow-up plan improve cardiovascular risk factors in adults aged ≥45 years?
Observational (n=865)
Does a pharmacist-led monitoring and follow-up plan improve cardiovascular risk factors in adults aged ≥45 years?
Pharmacist-led monitoring and follow-up significantly improves cardiovascular risk factors and ASCVD risk scores in adults over a 2-year period.
May support pharmacist roles in CV risk management for adults ≥45; extends observational data but leaves open need for RCTs before practice change.
OBJECTIVE: To assess the role of the pharmacist in modifying risk factors for cardiovascular disease (CVD) among Lebanese adults in urban and rural areas. METHODS: In a prospective survey, 865 out of 1,000 participants aged ≥45 years, previously interviewed, agreed to be followed at 1 and 2 years time points. Parameters including blood pressure, lipid profile, blood glucose, average number of risk factors, and atherosclerotic CVD (ASCVD) risk were assessed and evaluated at the beginning of the study, then after 1 and 2 years. RESULTS: During both follow-ups, the mean average body mass index and systolic blood pressure decreased significantly and the lipid profile improved significantly. Further significant improvements in ASCVD risk occurred during the second follow-up. Monitoring parameters revealed significant improvements as well. CONCLUSION: This study showed that a plan that includes pharmacists, who regularly monitor and follow-up patients, could improve CVD prevention through the reduction of risk factors.
No takes yet. Share an insight, caveat, or question.
Fahs et al. (2018) conducted an observational in Cardiovascular disease risk factors (n=865). Pharmacist monitoring and follow-up was evaluated on Modification of risk factors for cardiovascular disease including blood pressure, lipid profile, blood glucose, and ASCVD risk. Pharmacist monitoring and follow-up over 2 years significantly decreased body mass index and systolic blood pressure, and improved lipid profiles and ASCVD risk.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: